Robert M. Califf, MD, was sworn in as the new commissioner of the U.S. Food and Drug Administration (FDA) on February 17, 2022.
Previously, Dr. Califf served as FDA commissioner from February 2016–February 2017. Prior to rejoining the FDA, Dr. Califf was head of medical strategy and senior advisor at Alphabet Inc., contributing to strategy and policy for its health subsidiaries, Verily Life Sciences and Google Health. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute.
A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health-care quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,300 publications in the peer-reviewed literature.
Dr. Califf will now oversee the federal agency tasked with finalizing and implementing over-the-counter hearing aid regulations.
Recent Posts
A Virtual Reality System for Delivery of Military-Specific Vestibular Rehabilitation After Mild Traumatic Brain Injury: The Praxis Study Protocol
In an article by Alroumi et al. (2025), treatment of mild traumatic brain injury (mTBI) through the use of virtual reality (VR) system was investigated….
From Capitol Hill to Your Clinic: SPAN July Meeting on Medicaid Cuts
The State Policy Advocacy Network (SPAN) will convene again on July 29 for a critical meeting about Medicaid funding. SPAN brings together nationwide audiologists and…
EHDI Program at Risk
On April 1, President Trump’s administration eliminated the entire branch of the Early Hearing Detection and Intervention (EHDI) program that works with states to analyze…